Sort by Latest
UK Spring Budget – Streamlining regulation and plans for growth in life sciences
As part of last week’s Spring Budget, the UK Chancellor, Jeremy Hunt, announced increased funding of £10 million for the Medicines and Healthcare Products Regulatory Agency (the MHRA) over the next two years. This funding seeks to support the MHRA in facilitating faster routes for UK-developed medical products to obtain approval and launch on the market where “trusted regulatory partners” have already granted approval outside the UK. Plans in the Spring Budget also indicate a prioritisation of...
March 20, 2023
4 min read
LFSS 2023: creation of a new accreditation system for...
Article 53 of the Social Security Financing Act for 2023 (LFSS)...
February 21, 2023
2 min read
Reminder of the key requirements of the anti-gift law...
Breach of the “anti-gift” law An investigation...
February 2, 2023
3 min read
Guide to EU and UK Pharmaceutical Regulatory Law 2...
Eighth Edition, Edited by Sally Shorthose The Guide...
January 31, 2023
3 min read
The Legal 500: Pharmaceutical Advertising Comparative Guide 2022
The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The...
December 12, 2022
1 min read
Dialogue at EU level on the legalisation of recreational cannabis – the German Federal Government’s White Paper will not suffice
The Federal Government submits its White Paper on the legalisation of recreational cannabis to the...
December 1, 2022
11 min read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders....
November 22, 2022
8 min read
Update on the UK’s future medical device regulations: Extended timelines
The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) has recently announced the introduction...
October 31, 2022
2 min read
Blood, cells and tissues: regulatory change is coming
Approximately twenty years ago, the regulation of Substances of Human Origin (“SHO”)...
October 25, 2022
5 min read
Publication of the English version of the new French Clinical Trial Agreement templates
The French legislator recently updated the French clinical trial agreement template also called...
October 10, 2022
2 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.